Karah Herdman Parschauer Insider Profile
32 Followers
Karah Herdman Parschauer, EVP & CLO at Ultragenyx Pharmaceutical, holds 92.56K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 77.74K shares in Evolus (Ticker: EOLS), holds ― shares in Arcturus Therapeutics (Ticker: ARCT). Most recently, Karah Herdman Parschauer Sold ― shares of Ultragenyx Pharmaceutical on Aug 04, 2026 for an estimated value of $47.35K.
Karah Herdman Parschauer Ultragenyx Pharmaceutical (RARE)EVP & CLO
Ultragenyx Pharmaceutical (RARE)
EVP & CLO
Ranked #2,251 out of 109,193 Corporate Insiders
Profitable Transactions
18 out of 19 Profitable Transactions
Average Return
+30.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Karah Herdman Parschauer's holdings
Insider Roles
Roles that Karah Herdman Parschauer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karah Herdman Parschauer
Karah Herdman Parschauer's Trading History
Ultragenyx Pharmaceutical
Aug 04, 2026
EVP & CLO
Informative Sell
47.35K
$1.39M
Evolus
Feb 19, 2026
Director
Uninformative Buy
―
$621.94K
Arcturus Therapeutics
―
Director
―
―
Tenaya Therapeutics
―
Director
―
―
Anebulo Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Karah Herdman Parschauer's performance on stock
You May Also Like
Karah Herdman Parschauer insider profile FAQ
What is the percentage of profitable transactions made by Karah Herdman Parschauer?
The percentage of profitable transactions made by Karah Herdman Parschauer is 95%.
What is the average return per transaction made by Karah Herdman Parschauer?
The average return per transaction made by Karah Herdman Parschauer is 30.30%.
What stocks does Karah Herdman Parschauer hold?
Karah Herdman Parschauer holds: RARE, EOLS, ARCT, TNYA, ANEB stocks.
What was Karah Herdman Parschauer’s latest transaction?
Karah Herdman Parschauer latest transaction was an Informative Sell of $47.35K.
What was Karah Herdman Parschauer's most profitable transaction?
Karah Herdman Parschauer’s most profitable transaction was an Informative Sell of EOLS stock on March 14, 2025. The return on the trade was 62.00%.
What is Karah Herdman Parschauer's role in Ultragenyx Pharmaceutical?
Karah Herdman Parschauer's role in Ultragenyx Pharmaceutical is EVP & CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.